Search

Haiguang Xiao Phones & Addresses

  • Colmar, PA
  • Kissimmee, FL
  • 12 Barnum Pl, Ridgefield, CT 06877 (203) 942-2550
  • 120 York Dr, Princeton, NJ 08540 (609) 430-9962 (609) 683-1973
  • Solon, OH
  • Danbury, CT
  • Montgomery, PA

Work

Company: Janssen r&d Jan 2018 Position: Group leader, senior scientist

Industries

Pharmaceuticals

Resumes

Resumes

Haiguang Xiao Photo 1

Group Leader, Senior Scientist

View page
Location:
2001 Manufacturing Ct, Clinton, IA 52732
Industry:
Pharmaceuticals
Work:
Janssen R&D
Group Leader, Senior Scientist

Boehringer Ingelheim Dec 2009 - Dec 2017
Scientist Iv

Ge Healthcare Sep 1999 - Feb 2009
Senior Scientist

Publications

Us Patents

Multiply-Primed Amplification Of Circular Nucleic Acid Sequences

View page
US Patent:
20100105109, Apr 29, 2010
Filed:
Mar 18, 2008
Appl. No.:
12/532228
Inventors:
Haiguang Xiao - Princeton NJ, US
John R. Nelson - Clifton Park NY, US
Galina Chernaya - Princeton NJ, US
Haiying Wang - Bridgewater NJ, US
Paul Mitsis - Trenton NJ, US
Gyanendra Kumar - Somerset NJ, US
Carl F. Fuller - Berkeley Heights NJ, US
Yuyang Christine Cai - Cranbury NJ, US
Assignee:
GE Healthcare Bio-Sciences Corp. - Piscataway NJ
International Classification:
C12P 19/34
US Classification:
435 912
Abstract:
Improved processes for the amplification of target DNA sequences in the form of single or double stranded circular DNA molecules, especially those present in colony and plaque extracts, using multiple specific and/or random sequence oligonucleotide primers are disclosed. The product of this amplification is used for analysis by restriction enzyme digestion or DNA sequencing and other analyses that involve hybridization. Kits containing components for use in the method are also described. Also described are further uses of this amplified DNA in sequencing, genotyping and haplotyping, and other molecular biology applications.

Multiply-Primed Amplification Of Nucleic Acid Sequences

View page
US Patent:
20050239087, Oct 27, 2005
Filed:
Apr 29, 2004
Appl. No.:
10/835140
Inventors:
Haiguang Xiao - Princeton NJ, US
Scott Hamilton - Phillipsburg NJ, US
International Classification:
C12Q001/68
C12P019/34
US Classification:
435006000, 435091200
Abstract:
Improved processes for the amplification of target DNA sequences in the form of single or double stranded DNA molecules, especially those present in colony and plaque extracts, using multiple specific and/or random sequence oligonucleotide primers are disclosed along with methods for detecting such amplified target sequences wherein some or all of the deoxyribonucleotides are replaced by deoxyribonucleotide analogues that reduce the Tm of the amplified product. The product of this amplification is used for DNA sequencing and other analyses that involve hybridization. Kits containing components for use in the invention is also described. Also described are further uses of this amplified DNA in sequencing, single base substitution detection, modifying the restriction enzyme fragmentation patterns and other molecular biology applications.

Antibody Molecules For Cancer Treatment

View page
US Patent:
20210095020, Apr 1, 2021
Filed:
May 11, 2020
Appl. No.:
16/871382
Inventors:
- Ingelheim am Rhein, DE
Ivo LORENZ - Brooklyn NY, US
Otmar SCHAFF - Vienna, AT
Melanie WURM - Vienna, AT
Jean-Francois FORTIN - Laval, CA
Scott Ronald BRODEUR - New Hope PA, US
Keith A. CANADA - Freehold NJ, US
Lukasz CHLEWICKI - Indianapolis IN, US
Walter Carroll DAVIDSON - Croton NY, US
Pankaj GUPTA - Scarsdale NY, US
Priyanka GUPTA - Danbury CT, US
Rocío K. PÉREZ - Danbury CT, US
Haiguang XIAO - Ridgefield CT, US
Danlin YANG - Philadelphia PA, US
International Classification:
C07K 16/28
A61K 39/395
A61K 45/06
Abstract:
The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.

Anti-Trkb Antibodies

View page
US Patent:
20200399378, Dec 24, 2020
Filed:
Aug 26, 2020
Appl. No.:
17/002907
Inventors:
- Ingelheim am Rhein, DE
Remko Alexander BAKKER - Biberach an der Riss, DE
Sebastian BANDHOLTZ - Schemmerhofen, DE
Peter Michael BENZ - Veitshoechheim, DE
Michael DZIEGELEWSKI - Newburgh NY, US
Lore Katharina FLORIN - Redwood City CA, US
Cynthia Hess KENNY - Pearl River NY, US
Sarah Kathleen LOW - Carmel NY, US
Holger ROSENBROCK - Mittelbiberach, DE
Sanjaya SINGH - Blue Bell PA, US
Heiko Friedrich STAHL - Biberach, DE
Sathyadevi VENKATARAMANI - Blue Bell PA, US
Vladimir H. VOYNOV - Danbury CT, US
Haiguang XIAO - Ridgefield CT, US
International Classification:
C07K 16/28
A61P 25/28
Abstract:
The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.

Novel Anti-Baff Antibodies

View page
US Patent:
20190309034, Oct 10, 2019
Filed:
Jun 25, 2019
Appl. No.:
16/451333
Inventors:
- Ingelheim am Rhein, DE
Keith A. CANADA - Freehold NJ, US
Michael DZIEGELEWSKI - Newburgh NY, US
Philip Nicholas GORMAN - Prospect CT, US
Pankaj GUPTA - Scarsdale NY, US
Ashraf KHALIL - Hamden CT, US
John J. MIGLIETTA - Bethel CT, US
Amy Marie NICOLETTI - Derby CT, US
Qi PAN - Chappaqua NY, US
David PRESKY - Scottsdale AZ, US
Sanjaya SINGH - Blue Bell PA, US
Tao WU - Tucker GA, US
Haiguang XIAO - Ridgefield CT, US
International Classification:
C07K 14/475
A61K 39/395
C07K 16/28
C07K 16/24
Abstract:
The present invention relates to anti-BAFF antibody molecules, including novel humanized anti-BAFF antibodies, therapeutic and diagnostic methods and compositions for using the same.

Anti-Trkb Antibodies

View page
US Patent:
20180355046, Dec 13, 2018
Filed:
Jun 7, 2018
Appl. No.:
16/002058
Inventors:
- Ingelheim am Rhein, DE
Remko Alexander Bakker - Biberach an der Riss, DE
Sebastian Bandholtz - Schemmerhofen, DE
Peter Michael Benz - Veitshoechheim, DE
Michael Dziegelewski - Newburgh NY, US
Lore Florin - Danbury CT, US
Cynthia Hess Kenny - Pearl River NY, US
Sarah Low - Carmel NY, US
Holger Rosenbrock - Mittelbiberach, DE
Sanjaya Singh - Blue Bell PA, US
Heiko Friedrich Stahl - Biberach, DE
Sathyadevi Venkataramani - Blue Bell PA, US
Vladimir Voynov - Danbury CT, US
Haiguang Xiao - Ridgefield CT, US
International Classification:
C07K 16/28
A61P 25/28
Abstract:
The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.

Novel Anti-Baff Antibodies

View page
US Patent:
20180127474, May 10, 2018
Filed:
Nov 6, 2017
Appl. No.:
15/803993
Inventors:
- Ingelheim am Rhein, DE
Keith A. CANADA - Freehold NJ, US
Michael DZIEGELEWSKI - Newburgh NY, US
Philip Nicholas GORMAN - Prospect CT, US
Pankaj GUPTA - Scarsdale NY, US
Ashraf KHALIL - Hamden CT, US
John J. MIGLIETTA - Bethel CT, US
Amy Marie NICOLETTI - Derby CT, US
Qi PAN - Chappaqua NY, US
David PRESKY - Scottsdale AZ, US
Sanjaya SINGH - Blue Bell PA, US
Tao WU - Tucker GA, US
Haiguang XIAO - Ridgefield CT, US
International Classification:
C07K 14/475
C07K 16/28
Abstract:
The present invention relates to anti-BAFF antibody molecules, including novel humanized anti-BAFF antibodies, therapeutic and diagnostic methods and compositions for using the same.

Antibody Molecules For Cancer Treatment

View page
US Patent:
20170334995, Nov 23, 2017
Filed:
May 18, 2017
Appl. No.:
15/598356
Inventors:
- Ingelheim am Rhein, DE
Ivo LORENZ - Brooklyn NY, US
Otmar SCHAFF - Vienna, AT
Melanie WURM - Vienna, AT
Jean-Francois FORTIN - Laval, CA
Scott Ronald BRODEUR - New Hope PA, US
Keith A. CANADA - Freehold NJ, US
Lukasz CHLEWICKI - Indianapolis IN, US
Walter Carroll DAVIDSON - Croton NY, US
Pankaj GUPTA - Scarsdale NY, US
Priyanka GUPTA - Danbury CT, US
Rocío K. PÉREZ - Danbury CT, US
Haiguang XIAO - Ridgefield CT, US
Danlin YANG - Bethel CT, US
International Classification:
C07K 16/28
A61K 39/395
A61K 45/06
A61K 39/00
Abstract:
The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
Haiguang W Xiao from Colmar, PA, age ~62 Get Report